NeuroOne Medical Technologies Corporation
NASDAQ:NMTC
0.6152 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.453 | 1.952 | 0.171 | 0.178 | 1.927 | 0 | 0 | 0 | 0 | 0.001 | 0.001 | 0.001 | 0.001 | 0.005 | 0.001 |
| Cost of Revenue
| 2.373 | 1.496 | 0.242 | 0.276 | 1.863 | 0.028 | 0.022 | 0.018 | 0.008 | 0 | 0 | 0 | 0 | 0.002 | 0 |
| Gross Profit
| 1.08 | 0.457 | -0.071 | -0.098 | 0.063 | -0.028 | -0.022 | -0.018 | -0.008 | 0.001 | 0.001 | 0.001 | 0.001 | 0.003 | 0.001 |
| Gross Profit Ratio
| 0.313 | 0.234 | -0.414 | -0.549 | 0.033 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0.604 | 1 |
| Reseach & Development Expenses
| 5.065 | 6.941 | 4.929 | 3.925 | 2.076 | 1.529 | 0.951 | 0.735 | 0 | 0.002 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 6.753 | 6.709 | 6.26 | 4.753 | 4.284 | 3.216 | 2.337 | 0.189 | 0.008 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0.173 | 0.271 | 0.339 | 0 | 0 | 0.323 | 0 | -0.157 | 0.023 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 7.902 | 6.926 | 6.979 | 6.26 | 4.753 | 4.284 | 3.539 | 2.337 | 0.033 | 0.031 | 0.037 | 0.026 | 0.015 | 0.031 | 0.007 |
| Other Expenses
| 0 | -1.455 | 0.031 | 0.271 | 0 | 0 | 1.301 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 12.967 | 12.412 | 9.96 | 10.12 | 4.902 | 5.813 | 3.189 | 3.072 | 0.033 | 0.031 | 0.037 | 0.026 | 0.015 | 0.031 | 0.007 |
| Operating Income
| -11.887 | -11.955 | -10.031 | -10.218 | -4.902 | -5.813 | -3.211 | -3.072 | -0.033 | -0.031 | -0.036 | -0.02 | -0.014 | -0.027 | -0.006 |
| Operating Income Ratio
| -3.443 | -6.123 | -58.602 | -57.359 | -2.545 | 0 | 0 | 0 | 0 | -41.664 | -46.461 | -15.718 | -14.911 | -5.081 | -5.179 |
| Total Other Income Expenses Net
| -0.431 | 0.096 | 0.031 | 0.27 | -8.738 | -0.968 | -2.661 | -1.986 | 0.157 | 0 | -0 | -0.005 | -0 | -0 | 0 |
| Income Before Tax
| -12.318 | -11.859 | -10 | -9.948 | -13.64 | -6.781 | -6.827 | -5.058 | -0.033 | -0.031 | -0.036 | -0.031 | -0.014 | -0.028 | -0.006 |
| Income Before Tax Ratio
| -3.567 | -6.074 | -58.42 | -55.843 | -7.08 | 0 | 0 | 0 | 0 | -41.664 | -46.887 | -24.463 | -15.157 | -5.114 | -5.179 |
| Income Tax Expense
| 0 | 0 | -0.11 | 0.274 | 7.525 | 0.285 | 0 | 1.395 | 0.015 | 0.032 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -12.318 | -11.859 | -10 | -9.948 | -13.64 | -6.781 | -6.827 | -5.058 | -0.048 | -0.063 | -0.036 | -0.031 | -0.014 | -0.028 | -0.006 |
| Net Income Ratio
| -3.567 | -6.074 | -58.42 | -55.843 | -7.08 | 0 | 0 | 0 | 0 | -84.721 | -46.887 | -24.463 | -15.157 | -5.114 | -5.179 |
| EPS
| -0.46 | -0.65 | -0.63 | -0.93 | -2.52 | -1.72 | -2.43 | -2.3 | -0.028 | -0.037 | -0.021 | -0.018 | -0.008 | -0.018 | -0.004 |
| EPS Diluted
| -0.46 | -0.65 | -0.63 | -0.93 | -2.52 | -1.72 | -2.43 | -2.3 | -0.028 | -0.037 | -0.021 | -0.018 | -0.008 | -0.018 | -0.004 |
| EBITDA
| -11.842 | -11.756 | -9.912 | -9.798 | -4.855 | -5.786 | -4.145 | -3.055 | -0.033 | -0.031 | -0.036 | -0.025 | -0.014 | -0.027 | -0.006 |
| EBITDA Ratio
| -3.43 | -6.021 | -57.909 | -55 | -2.52 | 0 | 0 | 0 | 0 | -41.664 | -46.461 | -20.09 | -14.911 | -5.081 | -5.179 |